Relay Therapeutics Inc (NQ: RLAY )

7.400 +0.410 (+5.87%)

Streaming Delayed Price Updated: 10:12 AM EDT, Jul 11, 2024 Add to My Watchlist

Price and Volume

Volume	61,246
Open	7.230
Bid (Size)	7.390 (2)
Ask (Size)	7.410 (1)
Prev. Close	6.990
Today's Range	7.160 - 7.430
52wk Range	5.700 - 13.32
Shares Outstanding	121,613,181
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Clinical-Stage BioTech Drug Stocks Declined 13% In June

July 01, 2024

Our BioTech Drug Stocks Portfolio was DOWN 13.2% in June. Before proceeding read

Via Talk Markets

Largest Clinical-Stage BioTech Drug Stocks Declined 6%

June 22, 2024

Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they...

Via Talk Markets

Performance

YTD	-37.58%	-37.58%
1 Month	-1.73%	-1.73%
3 Month	+7.25%	+7.25%
6 Month	-36.32%	-36.32%
1 Year	-38.89%	-38.89%

More News

AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th

June 17, 2024

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week

June 10, 2024

Via Talk Markets

Expert Ratings For Relay Therapeutics

June 07, 2024

Via Benzinga

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

June 06, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Key Takeaways From Relay Therapeutics Analyst Ratings

May 10, 2024

Via Benzinga

Relay Therapeutics: Q4 Earnings Insights

February 22, 2024

Via Benzinga

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

June 05, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week

May 27, 2024

Via Talk Markets

Relay Therapeutics to Participate in Upcoming Investor Conferences

May 21, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

May 13, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

5 Of 7 AI Categories Rose, Slightly,Over Past Week

May 11, 2024

Via Talk Markets

The 7 AI Categories Declined, On Average, The First Week Of May

May 05, 2024

Via Talk Markets

Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May

May 05, 2024

Via Talk Markets

RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024

May 02, 2024

Via InvestorPlace

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

May 02, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024

April 25, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week

April 23, 2024

Via Talk Markets

Relay Therapeutics to Participate in Upcoming Investor Conferences

April 11, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session

April 10, 2024

Via Benzinga

AI Surge Ending: Only One Category Was Up This Week

April 06, 2024

Via Talk Markets

3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise

March 15, 2024

Via InvestorPlace

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD

March 04, 2024

Via Talk Markets

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

February 26, 2024

From Relay Therapeutics, Inc.

Via GlobeNewswire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Relay Therapeutics Inc (NQ: RLAY )

Price and Volume

Top News

Performance

More News